India Reports 263,000 TB Deaths in 2025 Amid WHO Concerns

A recent WHO report reveals alarming tuberculosis statistics in India, challenging government claims of progress in elimination efforts.

A
Aapla Nagpur Desk
16 Nov 2026, 8:22 AM IST · 2 min read
Source: Countercurrents
India Reports 263,000 TB Deaths in 2025 Amid WHO Concerns
KEY TAKEAWAYS
1

India recorded 263,000 TB-related deaths in 2025, accounting for 25% of global cases.

2

Jan Swasthya Abhiyan India demands transparency and improved strategies for TB treatment.

3

The financial burden of TB treatment continues to push affected families into debt.

On November 15, 2026, the National Coordination Committee of Jan Swasthya Abhiyan India (JSAI) raised serious concerns regarding India's tuberculosis (TB) crisis, following the release of the World Health Organization's (WHO) Global Tuberculosis Report 2026. The report, published on November 12, highlighted that India recorded 263,000 TB-related deaths in 2025, underscoring the urgent need for enhanced public health interventions as the country grapples with a significant TB burden.

India is responsible for approximately 25% of the global TB cases and 23% of TB-related deaths, making it the country with the highest incidence of the disease. The report indicated that India reported 2.53 million notified TB cases in 2025, a slight decrease from 2.618 million in 2024. Despite this minor decline, the loss of over 263,000 lives from a preventable and treatable disease remains a pressing public health issue.

The JSAI has called for increased transparency in TB data and immediate action to address the treatment gaps for drug-resistant TB. While the Union Ministry of Health reported a 38% reduction in estimated TB mortality from 2015 to 2025, JSAI argues that these statistics do not reflect the ongoing reality of TB-related deaths and suffering. The organization also expressed concern over the absence of India's 2025 TB incidence estimates in the WHO report, which hampers independent assessment of the country's TB burden.

The WHO report also pointed out significant deficiencies in the diagnosis and treatment of drug-resistant TB in India. The country has the largest treatment gap globally for rifampicin-resistant TB (RR-TB), with only 42% of those estimated to have developed RR-TB receiving treatment in 2025. JSAI emphasized the need for improved diagnostic infrastructure and timely access to treatment, particularly in underserved regions.

JSAI advocates for a comprehensive public health response to TB, addressing not only medical aspects but also the social determinants of health such as poverty and malnutrition. The organization has urged the government to adopt a rights-based approach to TB elimination, which includes timely publication of TB data, strengthening treatment facilities, and ensuring adequate nutritional support for patients. They stress that without addressing these underlying issues, the goal of TB elimination will remain unattainable.

💬What did you think of this story?What did you think?

Read Next

India's TB Deaths Reach 263,000 in 2025 - WHO Report